RG
Ravi Gangapalli
About Ravi Gangapalli
Data last updated:
Ravi Gangapalli has 16 years in corporate governance. Holds Managing Director and Director roles. Currently with 5 companies, including Gensynth Laboratories Private Limited and Vanshika Laboratories Private Limited. Formerly with 2 companies, such as Coastal Life Sciences Private Limited and Apex Drugs Limited. Engaged in General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹269 Cr; the largest is Surabhi Industries (India) Private Limited at ₹134 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surabhi Industries (India) Private Limited U24232TG2014PTC094692 | Whole-Time Director | 01 Oct 2016 | 2014 | ₹134 Cr (FY 2024) | Active |
 Gensynth Laboratories Private Limited U24230TG2004PTC044953 | Managing Director | 10 Oct 2020 | 2004 | ₹56.86 Cr (FY 2025) | Active |
| Surabhi Laboratories Private Limited U24304TG2020PTC140734 | Director | 10 Jun 2020 | 2020 | ₹49.91 Cr (FY 2025) | Active |
 Sivashakthi Laboratories Private Limited U24233TG2013PTC089770 | Director | 24 Dec 2018 | 2013 | ₹17.38 Cr (FY 2025) | Active |
| Vanshika Laboratories Private Limited U24230TG2021PTC151036 | Director | 02 May 2022 | 2021 | ₹11.45 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Coastal Life Sciences Private Limited U24233TG2010PTC068070 | Director | 23 Apr 2010 | 2010 | ₹52,200 (FY 2021) | Active |
 Apex Drugs Limited U24230TG1989PLC010737 | Whole-Time Director | 05 Feb 2015 | 1989 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Gangapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Gangapalli
Ravi Gangapalli has 16 years in corporate governance. Holds Managing Director and Director roles. Currently with 5 companies, including Gensynth Laboratories Private Limited and Vanshika Laboratories Private Limited. Formerly with 2 companies, such as Coastal Life Sciences Private Limited and Apex Drugs Limited. Engaged in General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹269 Cr; the largest is Surabhi Industries (India) Private Limited at ₹134 Cr (FY 2024).
Ravi Gangapalli is associated with 5 companies as Managing Director and Director, including Surabhi Industries (India) Private Limited (₹134 Cr), Gensynth Laboratories Private Limited (₹56.86 Cr), Surabhi Laboratories Private Limited (₹49.91 Cr).
Ravi Gangapalli has expertise in General Business.
Ravi Gangapalli has 16 years in corporate governance.
By reported revenue, the largest current company of Ravi Gangapalli is Surabhi Industries (India) Private Limited, with revenue of ₹134 Cr (FY 2024).
The 5 current companies of Ravi Gangapalli that report revenue have a combined latest revenue of ₹269 Cr.
Ravi Gangapalli currently holds positions at 5 companies: Surabhi Industries (India) Private Limited (₹134 Cr), Gensynth Laboratories Private Limited (₹56.86 Cr), Surabhi Laboratories Private Limited (₹49.91 Cr), Sivashakthi Laboratories Private Limited (₹17.38 Cr), Vanshika Laboratories Private Limited (₹11.45 Cr).